Mersana Therapeutics, Inc. (NASDAQ:MRSN) Sees Large Decline

Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) saw a significant decline in short interest during the month of December. As of December 15th, there was short interest totalling 8,460,000 shares, a decline of 28.7% from the November 30th total of 11,870,000 shares. Based on an average daily volume of 1,990,000 shares, the short-interest ratio […]

Related Keywords

, Vanguard Group Inc , Janssen Biotech Inc , Bellevue Group , Merck Kgaa , Citigroup , Asana Biosciences , Mersana Therapeutics Inc , Mersana Therapeutics Company Profile , Nasdaq , Blackrock Inc , Merck Kga , Mersana Therapeutics , Get Free Report , Street Corp , Janssen Biotech , Mersana Therapeutics Daily , Nasdaq Mrsn , Mrsn , Medical , Stocks , Options , Put , Call ,